VOR
Vor Biopharma (VOR)
$18
About Vor Biopharma (VOR)
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.
Details
Daily high
$8.43
Daily low
$7.91
Price at open
$8.43
52 Week High
$65.80
52 Week Low
$2.62
Market cap
179.2M
Dividend yield
0.00%
Volume
246,114
Avg. volume
1.1M
P/E ratio
-.02
Vor Biopharma News
Details
Daily high
$8.43
Daily low
$7.91
Price at open
$8.43
52 Week High
$65.80
52 Week Low
$2.62
Market cap
179.2M
Dividend yield
0.00%
Volume
246,114
Avg. volume
1.1M
P/E ratio
-.02